Richard E. Kaufman
Plus aucun poste en cours
Profil
Richard E.
Kaufman worked as a Director of Research & Development at Guidant Vascular Intervention and as a VP & GM of Bioabsorbable Vascular Solutions at Abbott Laboratories.
He then worked at Intersect ENT, Inc. for 11 years as COO and Senior VP of Research & Development.
Prior to that, he was a Principal at McGhan Medical SARL.
Kaufman received his undergraduate degree from Arizona State University.
Anciens postes connus de Richard E. Kaufman
| Sociétés | Poste | Fin |
|---|---|---|
| INTERSECT ENT, INC. | Chief Operating Officer | 29/10/2018 |
| McGhan Medical SARL | Corporate Officer/Principal | - |
| Guidant Vascular Intervention | Chief Tech/Sci/R&D Officer | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Formation de Richard E. Kaufman
| Arizona State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 3 |
|---|---|
Intersect ENT, Inc.
 Intersect ENT, Inc. Medical/Nursing ServicesHealth Services Intersect ENT, Inc. is a commercial drug delivery company, which engages in the treatment of ear, nose, and throat conditions. Its products include PROPEL and SINUVA. The PROPEL used to maintain the opening and locally deliver steroid after sinus surgery. The SINUVA is used to treat adult patients with ethmoid sinus surgery yet suffer from recurrent sinus obstruction due to polyps. The company was founded by Donald J. Eaton in October 2003 and is headquartered in Menlo Park, CA. | Health Services |
| Guidant Vascular Intervention | |
| McGhan Medical SARL | Distribution Services |
